tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
GANX
Gain Therapeutics
RESEARCH TOOLSreports

Gain Therapeutics (GANX) Income Statement

430 Followers

Gain Therapeutics Income Statement

Last quarter (Q4 2025), Gain Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Gain Therapeutics's net income was $-4.54M. See Gain Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 55.18K$ 132.64K$ 133.93K
Gross Profit
$ -94.05K$ 0.00$ 55.18K$ -8.11M$ -7.03M
Operating Expenses
$ 18.62M$ 20.35M$ 22.31M$ 9.67M$ 6.80M
Depreciation and Amortization
$ 94.05K$ 84.07K$ 83.58K$ 26.63K$ 15.48K
EBITDA
$ -18.62M$ -20.27M$ -22.17M$ -17.76M$ -13.82M
Operating Income
$ -18.71M$ -20.35M$ -22.25M$ -17.78M$ -13.83M
Other Income/Expenses
$ -589.28K$ 476.22K$ 64.89K$ 279.28K$ -60.42K
Pretax Income
$ -19.30M$ -19.87M$ -22.19M$ -17.50M$ -13.89M
Net Income
$ -20.16M$ -20.41M$ -22.27M$ -17.59M$ -13.89M
Per Share Metrics
Basic EPS
$ -0.61$ -0.89$ -1.71$ -1.48$ -1.37
Diluted EPS
$ -0.61$ -0.89$ -1.71$ -1.48$ -1.37
Weighted Average Shares Outstanding
 32.97M 22.88M 13.01M 11.88M 10.17M
Weighted Average Shares Outstanding (Diluted)
 32.97M 22.88M 13.01M 11.88M 10.17M
Currency in USD

Gain Therapeutics Earnings and Revenue History